Literature DB >> 9620348

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

F Pessione1, F Degos, P Marcellin, V Duchatelle, C Njapoum, M Martinot-Peignoux, C Degott, D Valla, S Erlinger, B Rueff.   

Abstract

The role of alcohol intake in the occurrence of severe liver disease in chronic hepatitis C virus (HCV) carriers is still debated. A cross-sectional study has been conducted in 233 chronic hepatitis C virus carriers. Weekly self-reported alcohol consumption (SRAC) was evaluated, serum HCV RNA levels were measured by a branched DNA technique (Quantiplex 2.0) and HCV genotypes were determined. A liver biopsy was performed simultaneously and liver lesions were graded with the Knodell histological activity index. Data were examined by uni- and multivariate analyses. Alcohol consumption was relatively low (< 140 g/per week in 193/233 patients [80%]). We found a highly significant correlation between SRAC and serum HCV RNA levels (r = .26, P = .001). Fibrosis was significantly correlated with age and alcohol consumption. These results suggest that in HCV carriers, alcohol consumption, even with low alcohol intake, increases viremia and hepatic fibrosis. Chronic HCV carriers should be advised to avoid regular alcohol intake.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620348     DOI: 10.1002/hep.510270635

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  59 in total

1.  Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Authors:  Li Ye; Shihong Wang; Xu Wang; Yu Zhou; Jieliang Li; Yuri Persidsky; Wenzhe Ho
Journal:  Drug Alcohol Depend       Date:  2010-06-20       Impact factor: 4.492

2.  The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection.

Authors:  Elizabeth C Costenbader; William A Zule; Curtis M Coomes
Journal:  Drug Alcohol Depend       Date:  2007-02-22       Impact factor: 4.492

Review 3.  Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.

Authors:  C L Cooper; Curtis L Cooper; Paul MacPherson; William Cameron
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

Review 4.  Alcohol use and hepatitis C.

Authors:  Marion G Peters; Norah A Terrault
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Traveling young injection drug users at high risk for acquisition and transmission of viral infections.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Jamye Ford; Alan Paciorek; Paula J Lum
Journal:  Drug Alcohol Depend       Date:  2007-11-05       Impact factor: 4.492

Review 6.  Pathogenic interactions between alcohol and hepatitis C.

Authors:  Gyongyi Szabo
Journal:  Curr Gastroenterol Rep       Date:  2003-02

7.  Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.

Authors:  Dustin B Stephens; Jennifer R Havens
Journal:  J Stud Alcohol Drugs       Date:  2013-05       Impact factor: 2.582

8.  Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.

Authors:  Jennifer G Plebani; Carlos F Tirado; Helen M Pettinati; Kyle M Kampman; Joseph R Volpicelli; David W Oslin
Journal:  Addict Behav       Date:  2009-09-10       Impact factor: 3.913

9.  Lay management of chronic disease: a qualitative study of living with hepatitis C infection.

Authors:  Eleanor Palo Stoller; Noah J Webster; Carol E Blixen; Richard A McCormick; Adam T Perzynski; Stephanie W Kanuch; Neal V Dawson
Journal:  Am J Health Behav       Date:  2009 Jul-Aug

10.  Influence of cannabis use on severity of hepatitis C disease.

Authors:  Julie H Ishida; Marion G Peters; Chengshi Jin; Karly Louie; Vivian Tan; Peter Bacchetti; Norah A Terrault
Journal:  Clin Gastroenterol Hepatol       Date:  2008-01       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.